Sep 19 2016

Pharmaceutical industry news, articles, jobs, reports, advice and services

#pharma marketing # A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a. Slide Deck: Kinetic: A new approach shaping the future of advisory boards How many times have we attended meetings that have little direction, or no clear objectives and left feeling disinterested and disengaged? Our “Kinetic” consulting approach is set to change all. Alzheimer’s disease: reviewing the immediate treatment horizon Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer’s disease. Anthill …

Sep 18 2016

Market Research Reports and Industry Analysis

#market research # Find the market research reports and industry analysis you need.’s Profound solution allows you to maximize your research budget by purchasing only the specific data you need. Extract individual sections, tables, charts or graphs from our comprehensive collection of more than 800,000 market research reports from more than 200 publishers across nearly 700 industry sectors. With our Knowledge Center solution, you gain unlimited, company-wide access to an entire catalog of industry-specific market research reports for one fixed cost, providing your organization with both predictability of spend and reliability of coverage. Plus, you will reduce time and …

Sep 14 2016

Pharmaceutical News, Industry Analysis, Market Research Reports – Pharmaceutical Business Review

#pharmaceutical business # Pharmaceutical Business Review FDA approves Amgen’s BLINCYTO for pediatric acute lymphoblastic leukemia The US Food and Drug Administration (FDA) has approved Amgen’s supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Regulatory Affairs News Biogen’s Alzheimer’s drug gets FDA fast-track status By PBR Staff Writer The US Food and Drug Administration (FDA) has granted fast track designation to Biogen’s investigational Alzheimer’s disease (AD) treatment aducanumab. Production Manufacturing Process Production News Singapore sees first case of …